Related Experiment Video
Updated: Aug 1, 2026

10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
[Ocular changes in children with acute lymphoblastic leukemia].
Oftalmologicheskii Zhurnal
|January 1, 1989
Summary
Children with acute lymphoblastic leukemia experience eye changes, including disturbed blood flow in conjunctival vessels, especially during disease recurrence. Treatment with antiaggregants and angioprotectors improved ocular microcirculation.
Area of Science:
- Ophthalmology
- Pediatric Hematology
- Oncology
Context:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
- Ocular complications can arise during various stages of ALL.
- Understanding these changes is crucial for comprehensive patient care.
Purpose:
- To investigate the occurrence and nature of eye changes in children with acute lymphoblastic leukemia.
- To assess the impact of disease recurrence on ocular microcirculation.
- To evaluate the therapeutic effect of specific treatments on these eye changes.
Summary:
- Children diagnosed with acute lymphoblastic leukemia (ALL) exhibit ocular alterations throughout the disease's progression.
- Biomicroscopy revealed impaired blood flow within conjunctival vessels, more pronounced in patients experiencing ALL relapses.
- Administration of antiaggregants, angioprotectors, and general therapy positively modulated the microcirculation in ocular vessels.
Impact:
- Early detection of specific eye changes in ALL patients can enhance overall diagnosis.
- Targeted ocular assessments may lead to improved diagnostic accuracy and additional therapeutic strategies.
- Monitoring ocular microcirculation provides insights into disease status and treatment efficacy in pediatric ALL.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025